Jefferies Maintains Rating, PT On CME

Jefferies is maintaining its Buy rating and its $350 price target on CME Group (NASDAQ: CME) as the company pushes towards the end of the quarter.

According to Jefferies, “Core trends across CME's product set remain favorable. Heightened volatility as of late in energy and interest rates is likely to put an upward bias on 2Q11 EPS estimates. At ~14x 2012 EPS, we view CME as a compelling investment given current business trends, even in a "lower for longer" interest rate environment.”

CME closed Friday at $277.88.